James RW - Search Results

1

Modulated serum activities and concentrations of paraoxonase in high density lipoprotein deficiency states.

James RW, Blatter Garin MC, Calabresi L, Miccoli R, von Eckardstein A, Tilly-Kiesi M, Taskinen MR, Assmann G, Franceschini G. James RW, et al. Atherosclerosis. 1998 Jul;139(1):77-82. doi: 10.1016/s0021-9150(98)00058-6. Atherosclerosis. 1998. PMID: 9699894

2

Paraoxonase-1 and serum concentrations of HDL-cholesterol and apoA-I.

Blatter Garin MC, Moren X, James RW. Blatter Garin MC, et al. Among authors: james rw. J Lipid Res. 2006 Mar;47(3):515-20. doi: 10.1194/jlr.M500281-JLR200. Epub 2005 Dec 3. J Lipid Res. 2006. PMID: 16327022 Free article.

3

Quantification of human serum paraoxonase by enzyme-linked immunoassay: population differences in protein concentrations.

Blatter Garin MC, Abbott C, Messmer S, Mackness M, Durrington P, Pometta D, James RW. Blatter Garin MC, et al. Among authors: james rw. Biochem J. 1994 Dec 1;304 ( Pt 2)(Pt 2):549-54. doi: 10.1042/bj3040549. Biochem J. 1994. PMID: 7998991 Free PMC article.

4

Enzymatically active paraoxonase-1 is located at the external membrane of producing cells and released by a high affinity, saturable, desorption mechanism.

Deakin S, Leviev I, Gomaraschi M, Calabresi L, Franceschini G, James RW. Deakin S, et al. Among authors: james rw. J Biol Chem. 2002 Feb 8;277(6):4301-8. doi: 10.1074/jbc.M107440200. Epub 2001 Nov 28. J Biol Chem. 2002. PMID: 11726658 Free article.

5

HDL subfraction distribution of paraoxonase-1 and its relevance to enzyme activity and resistance to oxidative stress.

Moren X, Deakin S, Liu ML, Taskinen MR, James RW. Moren X, et al. Among authors: james rw. J Lipid Res. 2008 Jun;49(6):1246-53. doi: 10.1194/jlr.M700439-JLR200. Epub 2008 Feb 26. J Lipid Res. 2008. PMID: 18314464 Free article.

6

Aspirin use is associated with higher serum concentrations of the anti-oxidant enzyme, paraoxonase-1.

Blatter-Garin MC, Kalix B, De Pree S, James RW. Blatter-Garin MC, et al. Among authors: james rw. Diabetologia. 2003 Apr;46(4):593-4. doi: 10.1007/s00125-003-1065-0. Epub 2003 Mar 22. Diabetologia. 2003. PMID: 12739030 No abstract available.

7

Very low density lipoproteins provide a vector for secretion of paraoxonase-1 from cells.

Deakin S, Moren X, James RW. Deakin S, et al. Among authors: james rw. Atherosclerosis. 2005 Mar;179(1):17-25. doi: 10.1016/j.atherosclerosis.2004.08.039. Epub 2004 Dec 7. Atherosclerosis. 2005. PMID: 15721005

8

High expressor paraoxonase PON1 gene promoter polymorphisms are associated with reduced risk of vascular disease in younger coronary patients.

Leviev I, Poirier O, Nicaud V, Evans A, Kee F, Arveiler D, Morrisson C, Cambien F, James RW. Leviev I, et al. Among authors: james rw. Atherosclerosis. 2002 Apr;161(2):463-7. doi: 10.1016/s0021-9150(01)00668-2. Atherosclerosis. 2002. PMID: 11888532

9

An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia.

Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, Franceschini G. Calabresi L, et al. Among authors: james rw. Metabolism. 2004 Feb;53(2):153-8. doi: 10.1016/j.metabol.2003.09.007. Metabolism. 2004. PMID: 14767865 Clinical Trial.

10

High density lipoprotein (HDL) subfractions in cardiovascular patients with low levels of HDL-cholesterol. Influence of hypertriglyceridaemia on subfraction concentration and composition.

Hong ML, James RW, Grab B, Pometta D. Hong ML, et al. Among authors: james rw. Atherosclerosis. 1988 Feb;69(2-3):241-8. doi: 10.1016/0021-9150(88)90020-2. Atherosclerosis. 1988. PMID: 3126751

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters